Sökning: WFRF:(Chalmers E)
> (2020-2024) >
Prescription and di...
Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting
-
- af Geijerstam, Peder, Doktorand, 1983- (författare)
- Linköpings universitet,Avdelningen för prevention, rehabilitering och nära vård,Medicinska fakulteten,Region Östergötland, Vårdcentralen Cityhälsan Centrum,The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia
-
- Falster, Michael O (författare)
- School of Population Health, University of New South Wales, Sydney, Australia
-
- Chalmers, John (författare)
- The George Institute for Global Health, University of New South Wales, Sydney, Australia
-
visa fler...
-
- McLachlan, Andrew J (författare)
- Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
-
- Rodgers, Anthony (författare)
- The George Institute for Global Health, University of New South Wales, Sydney, Australia
-
- Schutte, Aletta E. (författare)
- The George Institute for Global Health, University of New South Wales, Sydney, Australia
-
visa färre...
-
(creator_code:org_t)
- 2024
- 2024
- Engelska.
-
Ingår i: Hypertension Research. - : Springer Nature. - 0916-9636 .- 1348-4214.
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The duration of treatment for which a physician may prescribe a medicine, ‘prescription duration’, is often dispensed at the pharmacy on multiple occasions of shorter time periods, ‘dispensing duration’. These durations vary significantly between and within countries. In Australia, the quantity of medication supplied at each dispensing has recently been extended from 30 to 60 days for a selection of medicines used for chronic health conditions, such as diabetes and hypertension. Dispensing durations vary between countries, with 30, 60 or 90 days being the most common—with 90 days aligning with the recommendation of the 2023 Global Report on Hypertension from the World Health Organization. The full impact of shorter vs longer prescription durations on health costs and outcomes is unknown, but current evidence suggests that 90-day dispensing could reduce costs and improve patient convenience and adherence. More rigorous research is needed.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Nyckelord
- Hypertension
- prescription duration
- dispensing duration
- medication
- Hypertoni
- förskrivningstid
- dispensionstid
- läkemedel
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas